The largest head-to-head study to date between two leading drugs to treat opioid addiction has found them roughly equivalent — an outcome that could dramatically change prescribing habits and boost the fortunes of the newer drug, Vivitrol.
Trending:
Long-awaited study finds monthly Vivitrol as effective as daily pill for opioid addiction